Friday, 15 June 2018

Audiology Project Webinar: Diabetes and Audiological Monitoring of Ototoxic/Vestibulotoxic Medications, to be Held on Tuesday, June 26th

Posted in ADA News

Register for the Audiology Project Webinar: Diabetes and Audiological Monitoring of Ototoxic/Vestibulotoxic Medications, to be Held on Tuesday, June 26th, at Noon Eastern

Webinar presented by: The Audiology Project
Presenter: Robert M. DiSogra, AuD, FAAA and Michelle B. Mcelhannon, PharmD
Date: Tuesday, June 26, 2018
Time: 12:30-1:30 pm EDT

Click here to register

The association between diabetes and hearing loss continues to be unrecognized by many health care practitioners. Diabetes is a complex disease state requiring a multi-faceted approach to management. The ABC’s of diabetes treatment will be presented, as will be the approach to managing common complications. With complicated disease states comes complicated medication regimens. Recognition and management of the barriers to adherence in diabetic patients will be outlined.

There are at least 59 prescription medications (including oral and injectables) for patients with diabetes that have auditory, vestibular and/or cognitive side effects. Not knowing which medications have these side effects could lead to inappropriate recommendations thus leading to management errors.

Therefore, the 2nd half of this two part program will review the signs and symptoms of hearing loss in adults and who is considered “at risk.” Next, there will be a review of the diabetes medications that could cause any one or all of these side effects. The program continues with a discussion about the importance of audiometric testing for Type II diabetes patients as well as for patients who might be “at risk” for diabetes.

Finally, because the internet is a major source of reliable and oftentimes questionable drug information several preferred websites will be suggested to obtain up-to-date drug information (including side effects).

Suggestions for improved communication strategies between the referring physician, the patient and their pharmacist are given at the end of the program.

Join us for a Webinar on Tuesday, June 26, 2018 at 12:30 PM EDT

Click here to register